Home - Products - Others - Other Targets - Pinoresinol monomethyl ether 4-O-β-D-glucoside

Pinoresinol monomethyl ether 4-O-β-D-glucoside

CAS No. 74957-57-6

Pinoresinol monomethyl ether 4-O-β-D-glucoside( ——— )

Catalog No. M38272 CAS No. 74957-57-6

(+)-Pinoresinol monomethyl ether O-β-D-glucoside (Compound 6) is a natural product that can be isolated from the stems of Tinospora sinensis.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG Get Quote Get Quote
50MG Get Quote Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Pinoresinol monomethyl ether 4-O-β-D-glucoside
  • Note
    Research use only, not for human use.
  • Brief Description
    (+)-Pinoresinol monomethyl ether O-β-D-glucoside (Compound 6) is a natural product that can be isolated from the stems of Tinospora sinensis.
  • Description
    (+)-Pinoresinol monomethyl ether 4-O-β-D-glucoside is a natural product.
  • In Vitro
    ———
  • In Vivo
    ———
  • Synonyms
    ———
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ———
  • Research Area
    ———
  • Indication
    ———

Chemical Information

  • CAS Number
    74957-57-6
  • Formula Weight
    534.552
  • Molecular Formula
    C27H34O11
  • Purity
    >98% (HPLC)
  • Solubility
    ———
  • SMILES
    ———
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Li W, et al. New lignan glucosides from the stems of Tinospora sinensis. Chem Pharm Bull (Tokyo). 2004 May;52(5):638-40.?
molnova catalog
related products
  • CCG 50014

    CCG 50014 is a potent and selective inhibitor of RGS4 with IC50 of 30 nM.

  • Bupleuroside XIII

    Bupleuroside XIII is a natural hepatoprotective saponin.

  • Curculigoside

    Curculigoside can prevent bone loss , improve osteogenesis and inhibit osteoclastogenesis of hAFSCs, suggesting its potential use to regulate hAFSC osteogenic differentiation for treating bone disorders.